Lexston Life Sciences Corp.'s total assets for Q2 2026 were C$925.87K, an increase of 69.84% from the previous quarter. TSE:LEXT total liabilities were C$139.01K for the fiscal quarter, a 25.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.